| 17alpha-ethynylestradiol | affects expression | ISO | RGD:732665 | 6480464 | Ethinyl Estradiol affects the expression of PDPK1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:732665 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDPK1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:732664 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of PDPK1 mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732665 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDPK1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732665 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PDPK1 mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of PDPK1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of PDPK1 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:732664 | 6480464 | beta-methylcholine affects the expression of PDPK1 mRNA | CTD | PMID:21179406 |
| 4,4'-diaminodiphenylmethane | affects expression | ISO | RGD:732665 | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of PDPK1 mRNA | CTD | PMID:18648102 |
| amiloride | decreases phosphorylation | ISO | RGD:732664 | 6480464 | Amiloride results in decreased phosphorylation of PDPK1 protein | CTD | PMID:16059913 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PDPK1 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | decreases activity | ISO | RGD:732665 | 6480464 | arsenite results in decreased activity of PDPK1 protein | CTD | PMID:17520061 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:732665 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PDPK1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:732665 | 6480464 | Benzo(a)pyrene results in increased expression of PDPK1 mRNA | CTD | PMID:22228805 |
| cadmium atom | increases expression | ISO | RGD:732664 | 6480464 | Cadmium results in increased expression of PDPK1 protein | CTD | PMID:14499349 |
| celecoxib | decreases activity | ISO | RGD:732664 | 6480464 | celecoxib analog results in decreased activity of PDPK1 protein | CTD | PMID:15499625 |
| celecoxib | decreases activity | ISO | RGD:732664 | 6480464 | celecoxib results in decreased activity of PDPK1 protein | CTD | PMID:12000750 |
| celecoxib | multiple interactions | ISO | RGD:732664 | 6480464 | [atorvastatin co-treated with celecoxib] results in decreased phosphorylation of and results in decreased expression of PDPK1 protein | CTD | PMID:18172863 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:732665 | 6480464 | Ciguatoxins affects the expression of PDPK1 mRNA | CTD | PMID:18353800 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of PDPK1 mRNA | CTD | PMID:20187946 |
| diarsenic trioxide | decreases activity | ISO | RGD:732664 | 6480464 | arsenic trioxide results in decreased activity of PDPK1 protein | CTD | PMID:14633726 |
| doxorubicin | decreases response to substance | ISO | RGD:732664 | 6480464 | PDPK1 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:16782806 |
| doxorubicin | decreases expression | ISO | RGD:732665 | 6480464 | Doxorubicin results in decreased expression of PDPK1 protein | CTD | PMID:19429709 |
| elemental selenium | multiple interactions | ISO | RGD:732664 | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA | CTD | PMID:19244175 |
| lead diacetate | decreases expression | ISO | RGD:732665 | 6480464 | lead acetate results in decreased expression of PDPK1 mRNA | CTD | PMID:20542052 |
| microcystin-LR | increases phosphorylation | ISO | RGD:732664 | 6480464 | cyanoginosin LR results in increased phosphorylation of PDPK1 protein | CTD | PMID:20421190 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:732664 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL1B protein results in increased phosphorylation of PDPK1 protein] | CTD | PMID:17136479 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | decreases activity | ISO | RGD:732664 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in decreased activity of PDPK1 protein | CTD | PMID:17136479 |
| paclitaxel | decreases response to substance | ISO | RGD:732664 | 6480464 | PDPK1 protein results in decreased susceptibility to Paclitaxel | CTD | PMID:16782806 |
| paracetamol | decreases expression | ISO | RGD:732664 | 6480464 | Acetaminophen results in decreased expression of PDPK1 mRNA | CTD | PMID:22230336 |
| phenobarbital | decreases expression | ISO | RGD:732665 | 6480464 | Phenobarbital results in decreased expression of PDPK1 mRNA | CTD | PMID:23091169 |
| pirinixic acid | increases expression | ISO | RGD:732665 | 6480464 | pirinixic acid results in increased expression of PDPK1 mRNA | CTD | PMID:18301758 |
| progesterone | multiple interactions | ISO | RGD:732664 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of PDPK1 mRNA | CTD | PMID:17404688 |
| resveratrol | multiple interactions | ISO | RGD:732664 | 6480464 | resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of PDPK1 protein] | CTD | PMID:16343977 |
| resveratrol | multiple interactions | ISO | RGD:732665 | 6480464 | resveratrol promotes the reaction [PDPK1 gene mutant form results in increased expression of GSTK1 protein] | CTD | PMID:20980258 |
| resveratrol | decreases expression | ISO | RGD:732665 | 6480464 | resveratrol results in decreased expression of PDPK1 mRNA | CTD | PMID:22610192 |
| selenium atom | multiple interactions | ISO | RGD:732664 | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA | CTD | PMID:19244175 |
| trans-resveratrol | multiple interactions | ISO | RGD:732664 | 6480464 | resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of PDPK1 protein] | CTD | PMID:16343977 |
| trans-resveratrol | multiple interactions | ISO | RGD:732665 | 6480464 | resveratrol promotes the reaction [PDPK1 gene mutant form results in increased expression of GSTK1 protein] | CTD | PMID:20980258 |
| trans-resveratrol | decreases expression | ISO | RGD:732665 | 6480464 | resveratrol results in decreased expression of PDPK1 mRNA | CTD | PMID:22610192 |